Tatiana M. Prowell
MD
Medical Officer and Breast Cancer Scientific Lead
👥Biography 个人简介
Tatiana Prowell serves as breast cancer scientific lead at FDA and has championed pathologic complete response as a regulatory endpoint enabling accelerated approval in neoadjuvant breast cancer. Her work has shaped the contemporary framework for neoadjuvant trial design. She has advanced inclusive and innovative regulatory pathways.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Tatiana M. Prowell 的研究动态
Follow Tatiana M. Prowell's research updates
留下邮箱，当我们发布与 Tatiana M. Prowell（US Food and Drug Administration; Johns Hopkins）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment